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Effects of Dopamine on Left Ventricular Afterload and Contractile
State in Heart Failure: Relation to the Activation of
Beta,-Adrenoceptors and Dopamine Receptors
SOL 1 . RAJFER, MD, FACC, KENNETH M . BOROW, MD, FACC,
ROBERTO M, LANG, MD, FACC, ALEX NEUMANN, BS, JOHN D . CARROLL, MD
Chicago, Illinois
Although long-term therapy with oral beta-adrenoceptor
Alpinists, in patients with heart failure is generally associated
with the development of diminished pharmaealogic efficacy,
the ingestion of levodopa, which is decnrboxyleted
endoge-
nously to dopamine, is associated with a sustained improve-
ment in cardiac function
.
The beneficial hemodynamic
actions of dopamine to patients with heart failure have been
attributed to a positive inotrople effect that is mediated
through activation of beta,-adrenoceptors. However, a
reduction in left ventricular aflerload
resulting from the
activation of dopamine receptors may also lead to an
improvement in the performance of the failing heart .
To ascertain the relative importance of the positive
inotropic and aferload-reducing effects of dopamine in
patients with heart failure, dopamine (2, 4. 6 peglkg per
min), dobutamine (2, 6, 10 pg/kg per min) and nitroprus.
side (0.125 to 2 .0 tag/kg per min) were administered
to 13
patients mid, dilated cardiomyopalhy while monitoring left
ventricular wall thickness and dimensions by echocardiog
raphy and left ventricular and aortic pressures with a
Long-term therapy with oral beta-adrenoceptor agonists in
patients with heart 'ilure has been
limited by the eventual
development of diminished pharmacologic efficacy (1,2)
.
Tolerance to the hemodynamicactions o : beta-adrenoceptor
agonists has been attributed to down regulation of beta-
adrenucep[ors during sustained exposure to these agents (I) .
We have demonstrated (3), however, [hat long-term inges-
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mteromanometer-tipped catheter, Altering left ventricular
afterteod, quantified as eed-systolie oircumferentlal wall
stress, with nitroprusside allowed generation of the left
ventricular end-systolic circumferential wall stress-velocity
of fiber shortening relation that represented the baseline
contractile slate of the myocardium .
Left ventricular velocity of fiber shortening was elevated
during the administration of dohufmine and dopamine
when compared with measurements obtained with nitro.
prusside at the same left ventricular end-systolic circumfee.
ential wall stress. Furthermore, left ventricular end-systolic
wall stress decreased with dopamine but not with dobula.
mine . Thus, the beta,-adrenoceptor
activity of dopamine
And dobutamine augmented the contractile state of the
myocardium . The reduction in left ventricular aflerload
induced by dopamine but not dobutamine may reflect
activation of peripheral vas-
ar dopamine receptors by the
former-
(] Am Coll Cardiol 1988;12c498-58d)
lion of levodopa, which is decarboxylaled endogenously to
dopamine, produces a sustained improvement in cardiac
function in patients with heart failure ; changes in cardiac
index induced by levodopa correlated with the generation of
substantial amounts of deperuine . Although the hemody-
namic responses to levodopa can be attributed to a positive
inotropic effect due to activation of rnyocarlial beta,-
adrenaceptors by dopamine derived from levndnpa, stimu-
lation of dopamine vascular (DA,) receptors, resulting in
dilation of arterial vessels and a reduction in left ventricular
aflerload, may also contribute to the improvement in cardiac
performance elicited by dopamine (4) .
To ascertain the relative roles of aflerload reduction and
positive inotropic activity in determining
the hemodynaneic
responses to dopamine. we undertook this study in which we
examined the effects of dopamine and dobutamine on the left
9735-E197a88r53.5o
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ventricular end-systolic wall stress-velocity of fiber shorten-
ing (rate corrected) relation (5,6) . This relation is a sensitive
index of left ventricular contractility that is independent of
preload and incorporates both afterload and heart rate (7) .
Methods
Study patients. Thirteen patients with dilated cardiomyo-
pathy were studied . Patients enrolled in the study demon-
strated on echocardiographic examination a diffusely hypo-
kinetic, dilated left ventricle with a shortening fraction
s21% . There were nine men and four women whose ;es
ranged from 25 to 62 years (mean ± SD 46 ± I1), Four
patients were classified as meeting the criteria for New York
Heart Association functional class IV, six were in class III
and three were in class IL The origin of the dilated cardio-
myopathy was idiopathic in 12 patients and dozorubicin
cardiotoxicity in I patient . (Data obtained in the latter
patient were similar to those observed in the rest of the study
group .) Five patients had a prior history of systemic hyper-
tension . No patient had a history of myocardial infarction or
angina pectoris ; however, mild to moderate coronary artery
disease (one to two vessels with 50% diameter narrowing)
was present in five patients. There was no evidence of
significant regional wall motion abnormality on two-
dimensional echocardiographic study nor was myocardial
ischemia considered to be an important cause of the diffusely
hypokinetic, dilated left ventricle of these patients . The
presence of mitral regurgitation was assessed by left ventri-
cular angiography or pulsed Doppler echocardiography or
both ; eight subjects had no evidence of significant mitral
regurgitation and five had moderate regurgitation .
Written informed consent was obtained from each pa-
tient . The protocol was approved by the University of
Chicago Clinical Investigation Committee,
Hemodynalnic measurements. Patients were evaluated in
the fasting state and after premedication with diazepam (5
mg orally) and atropine (0 .5 mg subcutaneously) . Diuretics
were discontinued 12 h before tl .e study period whereas
digoxin was withheld on the morning of the study . Vasodi-
lators were discontinued at least 48 h before the acquisition
of hemodynamic measurements . Each patient underwent
right and left heart catheterization performed from the
femoral vein and artery, respectively . A Millar catheter with
a high fidelity pressure transducer at the distal end was used
to measure left ventricular pressures and the peak rate at rise
in left ventricular pressure (peak positive dP/dl( ; central
aortic pressure was measured with an additional high fidelity
pressure transducer 5 cm proximal to the distal end . The
catheter tip was soaked in warm saline solution for 45 to 60
min before calibration and subsequent insertion . The side
port of the arterial sheath was used for pressure reference
relative to micromanometer pressures. A tripie lumen, bal-
loon-tipped thermodilution catheter was placed with its
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distal end in the pulmonary artery and its proximal port in
the right atrium . The side port of a venous sheath was used
for drug administration. The electrocardiogram (ECG) was
monitored continuously and the heart rate was measured
from the simultaneous ECG signal .
Pressure tracings and the surface ECG were recorded
simultaneously on a Hewlett-Packard recorder (4560C) . Car-
din output was determined by the thermodilation method
using a computer (Edwards Laboratories, model 9520A) and
averaging three replicate determinations that varied <10%
(when values varied by >I0%, five consecutive determina-
tions were averaged) .
Ultrasound imaging )Hewlerr-Porkard)
was performed
with a 3 .5 dfHz rransdacer. Two-dimensionally targeted
M-mode echocardiographic recordings of the left ventricular
cavity were performed with simultaneous pressure tracings.
The papillary muscles and mitral apparatus were used as
internal landmarks to ensure a stable and reproducible
position for left ventricular cavity measurements . Real time,
two-dimensional echocardiographic imaging allowed on-line
assessment of regional wall motion abnormalities .
Drug administration. Control hemodynamic measure-
mews were obtained I) when a stable baseline was estab-
lished . and 2) w20 min after placement of all catheters .
Dopamine and dobutamine were administered to each pa-
tient sequentially, with the order of administration alternat-
ing among successive patients . Dopamine was infused ini-
tially at a rate of 2 µg/kg per min that was subsequently
increased at 10 min intervals to 4 and 6 gg/kg per min .
Dobutamine was infused sequentially in similar fashion at
rates of 2, 6 and 10 1ag/kg per min. After each drug infusion
was completed, a minimum of IS min elapsed before the
beginning of a new control period and establishment of a
stable hemodynamic baseline . In addition, a graded infusion
of nitroprusside was administered either before or after the
infusions of dopamine and dobutamine at doses of 0 .125,
0 .25. 0.5, 1 .0 and 2 .0 Ag/kg per min; nitroprusside was
discontinued before achieving the peak rate if the systolic
arterial pressure decreased to 90 mm Hg. The dosage of
nitroprusside was increased at 5 min intervals until the peak
infusion rate was achieved ; the latter was maintained for 10
min . When terminating the infusion of nitroprusside, a
minimum of 15 min was allowed for establishment of a stable
hemodynamic baseline. For each drug, hemodynamic mea-
surements and ultrasound images were acquired just before
each increment in dosage and 10 min after the peak infusion
rate was achieved . (During the administration of nitroprus-
side, cardiac output was measured only at baseline and at the
peak infusion rate
.) Comparable measurements were ob-
mined during the three control periods .
One patient dia not receive dopamine at a rate of 6 µg/kg
per min because an increase in left ventricular end-diastolic
pressure from 21 to 29 mm Hg was noted at a rate of 4 pg/kg
per min . Four patients did not receive dobutamine at a rate
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of 10 pug/kg per min because, when dobutamine was infused
at a rate of 6 µg/kg per min, an increase in heart rate >10
beats/min was observed (two subjects), an increase in uni-
form, premature ventricular complexes was noted (one
patient) or an increase in systolic arterial pressure of 20 mm
Hg was recorded (one patent) . On completion of the drug
infusions, coronary arteriography (Judkins technique) was
performed in all patients.
Data analysis. Left ventricular end-diastolic and end-
systolic minor axis dimensions (D_ D am,) as well as end-
systolic wall thickness (h,,) were measured from parasternal
two-dimensionally targeted M-mode echocardiographic re-
cordings acquired perpendicular to the left ventricular long
axis end through the midline of short-axis images . Care was
taken to record the largest left ventricular minor axis dimen-
sions present between the tips of the mitral valve leaflets and
the superior aspect or the papillary muscles (that is, approx-
imately at the equatorial plane of the ventricle) . In addition,
the left ventricular end-systolic long-axis dimension (L,,)
was obtained using two-dimensional echocardiography per-
formed with the transducer at the apical four chamber
position and was measured as the longest distance from the
apical endocardium to the midportion of the mitral valve
anulus . The apical endocardium was defined as the point
within the left ventricle in which the septum and lateral wall
formed the most acute angle . This was accomplished by
positioning the transducer as far lateral or inferior, or both,
as necessary . The distance from the apex to the midportion
of the mitral valve anulus was maximized while simulta-
neously the width of the anulus was also maximized . Tan-
gential imaging of the left ventricle was avoided by using this
approach . The peak of the R wave of the ECG and the
dicrotic notch of the central aortic pressure tracing were
used to designate end-diastole and end-systole, respectively.
Left ventricalar percent fractional shortening (%
a D)
was calculated as (D.a - D,,)/D- Left ventricular end-
systolic pressure (P,,) was determined directly from the
incisura of the aortic pressure tracing
. Left ventricular
ejection time (LVET/ was measured from the central aortic
pressure in the standard manner . Rate-corrected, left ven-
tricular mean velocity of fiber shortening (Vcf f , circumfer-
enrcs/s) was calculated as (7):
Vcf,=
9AD
LVET
V_RR
where RR = the interval between consecutive cardiac cycles
as determined from the ECG .
Left veatricrdar end-systolic meridivnal n-a11 stress (a m,.,)
was calculated as the product of left ventricular end-systolic
pressure and a geometric factor that includes dimension and
wall thickness
. The following angiographically validated
formula was used (8) :
Wall stress = [Pressure] [Geometric factor]
ms
= Pr,
Ih„ I + (tk,JD.,)
/j
where am„ is in grams per square centimeter, De , and he, are
in centimeters, and Pa „ which is expressed in units of
millimeters of mercury is converted to grams per square
centimeter by multiplying by 1 .35 . In a similar manner, left
ventricular end-systolic circumferential wall stress (a., [g/
cm 2]) was calculated using the equation of Sandier and
Dodge (9) :
Wall stress = [Pressure] [Geometric factor]
D„ D„
-,=P"
2h,~
1
2L`
;(D„+h„))]x(1
.751 .
where L„ = left ventricular end-systolic long-axis dimen-
sion (in centimeters) .
Left ventricular contractile state was assessed with the
use of the load-independent relation between left ventricular
end-systolic wall stress and rate-corrected velocity of fiber
shortening (7). For each subject, the baseline relation was
determined by linear regression analysis (least-squares
method) using a minimum of four data points acquired under
control conditions and during the administration of nitro-
prusside; thus, measurements were obtained over a wide
range of afterload conditions
. For individual values obtained
during the infusion of dopamine and dobutamine, the vertical
distance above this regression line was used to estimate left
ventricular contractile response (A Vcfc) (6,10) .
Derived heriodynamic variables were calculated as Job
lours : cardiac index (liters/min per m 2) = cardiac output
(liters/min)/body surface area (m'-), systemic vascular resis-
tance (dyne.s.cm -s)= (mean systemic arterial pressure (mm
Hg) - mean right atria) pressure [mm Hg]) x 1332
dyne-cm 2 .mm Hg '/cardiac output halts).
Statistical analyses. All values are expressed as mean t
SD . Statistical analyses involving comparisons of control
measurements with data obtained during the infusions of
dopamine and dobutamine were accomplished by using the r
test for paired samples and the Bonferroni correction for
multiple comparisons (II). Statistical significance was ac-
cepted at a p value <0 .05/k, where k is the number of
comparisons performed . Measurements obtained before and
after the infusion (peak rate) of nitmprusside were compared
using the t test for paired samples . A p value <0 .05 was
considered indicative of statistical significance,
Results
Nitroprusside
Hem,alynamic data. The hemodynamic data obtained be-
fore the administration of nitroprusside and during its peak
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Table 1 . Hemodynamic Responses to Nitroprusside in 13 Patients
With Congestive He.,[ Failure
'p < 0.05 far the difference from the control valve. Values arc mean -.
SD
. Dr4 and D„ = left ventricular end-diastolic and end .systolis minor axis
dimension
. respectively dPldr = rate of rise in lea ventricular pressure ; h,, _
left ventricular end-systolic wall thickness : L„ = lea ventneular end-systolic
long-axis dimension; LVEDP = lea ventricular endcdiuslolx pressure ; P„ _
lea sent tenter end-systolic pressure
; RA = right atrial ; SVR = systemic
vascular resistance; Vcf, = rate-corrected lea ventricular mean velocity of
fiber shortening
: yr = left ventricular end-syslnlic circumferential wall
stress ; a,5, = lea ventricular end-systolic meridiomi wall stress,
rate of infusion are sumenariced in Table I . Mean arterial
pressure and systemic vascular resistance decreased with
the administration of nitroprusside . A reduction in the ele-
vated baseline left ventricular end-diastolic and mean right
atrial pressures was also observed . Cardiac index (control =
2
.19 ± 0.60 literslmin per m'-) and peak positive dP/di
(control = 905 ± 317 mm Hgls) did not change significantly
during the infusion of nitroprusside
. Heart rate was not
altered appreciably.
Wall stress . Left ventricular systolic fiber load (that is,
afterload) was measured as end-systolic wall stress (12 .13).
At the peak infusion rate of nitroprusside, left ventricular
end-systolic circumferential wall stress declined from 233 5
51 to 195 ± 52g/cm'-
(p < 0
.05), a decrease of 16%, A similar
reduction in left ventricular end-systolic meridional wall
stress was observed (from 126
t
41 to 105 ± 39
g/cm2,
p <
0.05). Examination of the physiologic factors regulating tell
ventricular end-systolic wall stress revealed that a substan-
tial decline in left ventricular end-systolic pressure occurred
and was accompanied by a reduction in left ventricular
end-systolic cavity size : left ventricular wall thickness in-
creased slightly .
Left ventricular performance . The administration of ni-
troprusside resulted in an improvement in overall left ven-
tricular performance as measured by left ventricular velocity
of fiber shortening, which increased from 0 .43 t 0 .11 to 0 .47
± 0 .12 circumference/s (p < 0 .05) . The relation between left
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Figure 1, Values for left ventricular (LV) end-systolic circumferen-
tial wall stress and rato-correeted left ventricular velocity of fiber
shortening obtained before and after the administration of nitroprus-
side to a patient with dilated cardiomyopathy . The line of best fit
was determined by linear regression analysis . CNp = control value
before nilropmsside; PNP = value at peak infusion rate of nitropms-
side .
ventricular end-systolic circumferential wall stress and left
ventricular velocity of fiber shortening was determined for
each patient over a wide range of afterload conditions
generated by nitroprusside (Fig, I) . Because nitroprusside
does not alter left ventricular contractile state, the relation
depicted in Figure I represents the changes in left ventricular
velocity of fiber shortening (that is, overall left ventricular
performance) due purely to changes in left ventricular after-
load (measured as end-systolic circumferential wall stress) .
As end-systolic circumferential wall stress declined, left
ventricular velocity of fiber shortening increased as a result
of the decreased load . For each patient, a linear regression
line could be constructed to define this left ventricular
end-systolic circumferential wall stress-velocity of fiber
shortening relation and was identified as representing the
baseline contractile state (6,10) .
Doburainine
Hemodynamic data (Table 2) . The administration of do-
hutamine resulted in an increase in peak positive dP/dt and
cardiac index accompanied by a decrease in systemic vas-
cular resistance. Mean arterial pressure increased modestly,
achieving statistical significance at an infusion rate of 10 µg1
kg per min. Heart rate increased significantly at an infusion
rate of 10 µg/kg per min.
Although there was a slight tendency for the left ventri-
cular end-diastolic pressure to decrease during the infusion
of dobutamine, the reduction did not achieve statistical
significance ; left ventricular end-diastolic dimension was
unaltered . Significant changes from the baseline mean right
atrial pressure were not observed after the administration of
dobutamine.
Control Nitroprusside
Heart rate (bestslmin) 87 ± 13 88 * II
Cardiac index (literslmin per met 2.19 ± 0.60 2 .35 5 0 .52
Mean arterial pressure (mm HS) 94 5 21 86 5 18"
P" On . 1181
SVR(dynessern `)
101 s 25
1,772 5 547
89
559 0 327 -
Mean RA pressure (mm Hg)
LVEDP (mm Hg)
t0 *_ 5
25 *_ 8
17 855'
59'
D,a (cml 6 .93 x 0.96 6.75 5 I .tS•
De , ( 9m) 6.12
t
0.98 591 a 1 .05.
4„ (4m) 8 .41
1112
8.13
.
0.870
h„ (cml 1 .40 *_ 0.36 1 .03 5 0 .36-
,n-,(glcm') 126 a 41 10 5 39-
«, (glcme) 233 a 51 95 5 52-
VC
f,
.lcircumfesenms/s) 0.43±0.11 0 .47 0 .12-
Peak positve dPldt (mm Hill) 905 5 317
990 0 299
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Table 2
. Hemodynamic Responses to Dobalamine in 13 Patients With Congestive Heart Failure
'p
< 0
.016 forthe difference from the control value . Values are mean 0 SD; values in parentheses represent control measurements for n n 9 . Abbreviations
as in Table
I
.
Wall stress . During the infusion of dobutamine, left ven-
tricular end-systolic circumferential and meridional wall
stress exhibited a tendency to increase or remain unchanged .
When the physiologic factors that influence end-systolic wall
stress were examined, it was apparent that a significant
elevation in left ventricular end-systolic pressure was pro-
duced by dobutamine and this was counterbalanced by a
decrease in left ventricular end-systolic cavity size and an
augmentation in left ventricular end-systolic wall thickness .
Ventricular performance . In Figure 2, an example of the
baseline left ventricular end-systolic circumferential wall
stress-velocity of fiber shortening relation and changes pro-
duced by dobutamine are plotted for an individual subject .
The diagonal solid line represents the regression line defining
the baseline left ventricular end-systolic circumferential wall
stress-velocity of fiber shortening (Vcf) relation . Values
obtained just before and after the infusion of dobutamine are
labeled C00 and DB, respectively . For any data point, the
vertical deviation (AVcf) from the regression line indicates
the change in left ventricular velocity of fiber shortening
units at a given level of afterload (that is, left ventricular
end-systolic circumferential wall stress) . Because left ven-
tricular velocity of fiber shortening incorporates heart rate
and is independent of preload, A Vcf, represents the change
in left ventricular velocity of fiber shortening independent of
the effects of altered loading conditions and can be used to
assess the positive inotropic activity of dobutamine
(6,10) .
The results for the entire study group are presented in Figure
3 ; an increment in d Vcf was observed during the adminis-
tration of dobutamine
. Similar results were obtained using
left ventricular end-systolic meridional wall stress as the
index of left ventricular afterload.
Dopamine
Hemodynamie data (Table 3). The infusion of dopamine
produced an increment in cardiac index and peak positive
dP/dt in association with a decrease in systemic vascular
resistance ; left ventricular end-diastolic pressure did not
Figure 2 . Values forloft ventricular (LV)end-systolic circumferen-
lial wall stress and rate-corrected left ventricular velocity of fiber
shortening measured before and after the administration of dohula-
mine (DBI and dopamine (DA) to a patient with dilated cardiomyo-
pathy . The vertical deviation (AVcf) from the regression line
representing the baseline relation between left ventricular end-
systolic wall stress and velocity of fiber shortening is a measure of
the positive inotropic activity of dobutamine and dopamine .
CnA
=
control value before dopamine ; Coa = control value before John .
Immune: DA2, DA4, DA6 = values obtained with dopamine infused
at rotes of 2, 4 and 6 5ag)kg per min, respectively
; DB2, DB6, DB 10
= values obtained with dobutamine infused at rates of 2, 6 and 10
pg/kg per min, respectively .
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Dobutamine Into don
Control
in =131
2 pp/kg per
m
in In=131
6 ptStg per
min In = 131
10 Fog per
mints = 9)
Heart rate
(heats/min)
A8 t 3 89 s 12 92 z 15 95 0 12'(87
0
15)
Cardiac index (liters/min per m'-) 2.15 t 0 .68 2 .29 x 0 .79 2.6700.75' 2 .84±0.57'(1 .98±0 .561
Mean arterial pressure IRE Hg) 93
0
19 96 , 21 97 0 21 95 t 10' (88
0
11)
P,.,
(mm
Hg) 99 0 24 105 s 23' 104 x 25 103 0 12'(92 x 1 5)
SVR (dynesu,errr 1 1.869 0 568 1,832 0 643 1 .562 * 460 1,435 0 479' (1 .870 -_ 668)
Mean RA pressure [or. Hg) 9 0 6 9 t 5 805 8m6(10A6)
LVEDP Imm Hg) 24 t III 24 *- 12 22 t 12 21 0 12 (25 t 10)
D,a (en)
6
.84 *_ 0 .98 6.83 *- 1 .00 6 .73 *- 1 .07 7.08 0 0.98 (7.19
0
0.851
D., (cm) 6 .06 t 1 .02 6.01 x 1 .06 5 .82 x 1 .15' 6.18 0 1 .04' (0.43 0 0.86)
L,, (cm) 8 .30 0 0 .85 8 .23 0 0 .85 7 .9600 .97' 8.06 ±0.89' (8.40x0.811
14, Is .) 1 .40 1 .4110 .37 1 .46 0 0 .41' 1 .31 x 0.24' (1 .24 x 0.20)
m
„(gJ<me) 121 0 39 129 r 4fi
121!49 140
44 (137
32)
,,, (plan') 224 46 237 0 56- 224 0 64 249 0 55 (241 0 38)
W1,
(circumferencesls) 0 .44 0 0 .11 0.45 - 0.13 0 .5200 .18' 0.4800.15(0.4000.08)
Peak positive dP)dt turn Ha/s) 877 249 981 s 322- 1,176 0 487' 1,222 2 268' (789 0 163)
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Figure 3. Changes in rate-corrected lef ventricular (LV)velocityof
fiber shortening that can he attributed to the positive inotropic
activity of dopamine (DA) at infusion rates of 2, 4 and 6 µglkg per
min (DA2, DA4, DA6) and dobutamine at lutes of 2 .6 and 10 µgikg
per min (DB2, DB6, DBIO) . These values represent the deviation (A
Vcfe) from the baseline left ventricular end-systolic circumferential
wall stress-velocity of fiber shortening bate-corrected) relation .
Vertical hats denote SD .
change significantly . There was a tendency for mean arterial
pressure to increase at an infusion rate of 6 pglkg per min,
but this elevation did not achieve statistical significance .
Heart rate and mean right atrial pressure were not altered by
dopamine .
Wall stress, In contrast to dobutamine, left ventricular
end-systolic wall stress (meridional and circumferential)
decreased significantly during the administration of dopa-
mine at rates of 2 and 4 yuglkg per min . A decline in left
ventricular end-systolic cavity size and an augmentation in
left ventricular end-systolic wall thickness occurred with
dopamine; left ventricular end-systolic pressure was not
Table 3. Hemodynnmic Responses to Dopamine in 13 Patients With Congestive Heart Failure
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altered significantly . There was a tendency for left ventricu-
lar end-systolic pressure to increase when dopamine was
infused at a rate of 6
pag)kg per min; an increase was
observed in six patients, whereas a decrease was recorded in
the other six . The reduction in left ventricular end-systolic
wall stress recorded during the administration of dopamine
at a rate of 6 ,ag/kg per min did not achieve statistical
significance
.
Ventricular performance, The effects of dopamine on A
Vcfe represent changes due solely to its positive inotropic
action
. An increase in A Vcfe was observed during the
infusion of dopamine (Fig . 2 and 3) . As with dobutamine,
similar results were obtained using left ventricular end-
systolic meridional wall stress as the index of left ventricular
afterload
.
Discussion
The changes in left ventricular performance that are pro-
duced by a drug represent the amalgamation of its effects on
loading conditions, heart rate and contractility . Determining
the mechanisms responsible for the alteration in ventricular
function is usually not possible by simply analyzing tradi-
tional hemodynamic measurements. Accordingly, to assess
the relative contributions of aftertoad reduction and aug-
mented contractility in determining the hemodynamic re-
sponses to dopamine in patients with heart failure . we
compared the effects of dopamine and dobutamine on left
ventricular end-systolic wall stress, an index of left ventri-
cular aferload (12,13), and rate-corrected velocity of fiber
shortening. a measure of overall ventricular performance (7) .
Previous studies have demonstrated that the linear, inverse
'p 10.016 for the diueren .e from the control value . Valves are mean ± SD
. values in pmenthcses represent comrol measurarent, for n = 12 . Abbreviation
as in Table 1 .
Dapasri'c Infusion
Cnmml
In = 131
2 NrJkg per
min In = Ill
4 yckg per
min In = 13)
6 sVkg per
in . In = 12)
Heart rall (neatWmr) 85 -_ 13 84 1 11 83 t 9 83 t 10 (87 t 11)
Cardiac index Ililersmin per me) 2 .11 0 .63 2.41 0.651 2 .74 *- 0.72' 2 .90
t
0.66' 12
.10 t 0
.651
Mean arterial preasure (mm H8) 93 t 16 91 t I8 95 t 17 101 t 19(94 ! 16)
P,terHg) 99tIs 91x20 1011221 105m25(49a18)
SVR (dynes-, CM °I 1,841 a 581 1 .565 0 490' 1456 t 485' 1,443 t 355' (1,899 t 575)
Mean RA pressure (mm 140 10 ± 6 10 z 6 11 *_ 6 19 2 6(9
t
5)
LVEDP (Inm Hg) 24
t 8 24 ± 9 25 t 9 23 t 12(24 t 8)
U" lean
691'.11,95 6 .14x099' 6.82x1.02' 6 .7861,10(6.860098)
D_ km) 6.11 _ 1,0 597 a 1 .02` 5.80 t 1 .(14' 5.69 t 1 .119' 16.04 t 1.02)
L,, (cm)
8-39 c 1196
8 .18 » 0,90'
7.94 t 0.82' 7 .78 t 0.93' (829 t 0 .93)
h" (em)
1
.39
t
0
.37 1 .42 t 0 .36 1.48 t 0.37' 1 .54 t 0.39' (1,42 *_ 037)
Iglcm'I
124 t 42 Il6 x 39' 110 a 39' 110 t 46(122 *_ 43)
49 215
5
48'
208
t 53' 208 t 59(224 t 50)
Vcfe Icircumfrrenceslsl
11.44 _ 0,13
0.47 0 11.12 0 .55 a 0 .15` 0 .62'- 0.18' 10.45 t 0.131
Peak positive dPdllmm Hg) 877 ' 2_36 928 t 260 1,098 t 285' 1.330 a 360' (898
t
233)
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relation between left ventricular end-systolic wall stress and
velocity of fiber shortening can be utilized to distinguish the
effects of altered loading conditions from changes in contrac-
tile state (6,101
Pharmacologic actions of dopamine . Dopamine influences
the cardiovascular system by activating beta,-adrenocep-
tors, alpha-adrenoceptors and dopamine (DA) receptors
(14,15) . Dose-response relations for dopamine at these re-
ceptors are not identical and exhibit substantial variability
from patient to patient. Generally, dopamine receptors are
activated at the lowest infusion rates (0 .5 to 2.0 pglkg per
min)
. As the infusion rate is increased further, the effects of
beta,-adrenoceptor activation become evident ; at infusion
rates above 4 to 6 µg/kg per min, the recruitment of
alpha-adrenoceptors occurs . The beneficial hemodynamic
effects of dopamine in patients with heart failure have
usually been attributed to this agent's potent positive inotro-
pie action, which is mediated through activation of myocar-
dial beta,-adrenoceptors (16,17)
. However, its agonist active
ity at the DA, receptor results in vasodilation of the renal,
mesenteric, cerebral and coronary artery beds (15,17) ; thus,
activation of these receptors can lead to a decrease in left
ventricular afterload. On the other hand, activation of alpha-
adrenoceptors on vascular smooth muscle at high infusion
rates of dopamine will produce vasoconstriction, which may
increase left ventricular afterload and therefore have a
detrimental effect on left ventricular performance .
Effects of dopamine and dobutamine on left ventricular
mechanics. In this study the hemodynamic effects of dopa-
mine were compared with those elicited by dohutamine .
Dobutamine is a full agonist at the beta,-adrenoceptor and
possesses weak activity at the betai adrenoceptor (produces
vasodilation) and alpha,-adrenoceplor (subserves vasocon-
striction) (18); thus, hemodynamic responses to dobutamine
are essentially the result of its cardiotonic action
. We
utilized the relation between left ventricular end-systolic
wall stress and the rate-corrected velocity of fiber shortening
to assess changes in myocardial contractility . As expected,
dobutamine produced an augmentation in the contractile
state of the myocardium . However, left ventricular end-
systolic wall stress was either unchanged or exhibited a
tendency to increase during the administration of dobuta-
mine . Because left ventricular end-systolic wall stress is the
load that terminates left ventricular fiber shortening (12,13),
it appears that dobutamine did not effect a reduction in left
ventricular afterload . According to Laplace's law, left ven-
tricular wall stress is directly related to chamber dimension
and pressure and inversely related to wall thickness
(19) .
Although the administration of dobutamine resulted in a
decrease in left ventricular end-systolic dimension and an
increase iii wall thickness, an increase in end-systolic pres-
sure occurred and, thus .. left ventricular wall stress either
increased or was unaltered .
When
the
hemodyncr;ic effects of dopamine are onar-
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lyzed, an increment in myocardial contractility was also
documented . In contrast to dobutamine, dopamine caused a
decrease in left ventricular end-systolic wall stress . There
was a decrease in left ventricular end-systolic cavity size
accompanied by an increase in wall thickness ; left ventricu-
lar end-systolic pressure was unchanged . The differential
effects of dobutamine and dopamine on left ventricular
end-systolic wall stress may be due to the activation of DA,
receptors by the latter. Consistent with this interpretation,
Lang et al . (10) reported that norepinephrine, which acti-
vates beta,- and alpha-adrenoceptors, produced an augmen-
tation in left ventricular velocity of fiber shortening (adjusted
to eliminate the effects of altered loading conditions, as in
the present study) but left ventricular end-systolic wall stress
remained unchanged ; left ventricular end-systolic pressure
increased whereas the left ventricular geometric factor de-
creased (that is, left ventricular end-systolic cavity size
decreased and wall thickness increased)
. The administration
of utilrinone, a bipyridine derivative with cardiotonic and
vasodilating properties, elicited an increase in left ventricu-
lar velocity of fiber shortening and a decrease in left ven-
tricular end-systolic wall stress ; a reduction in the left ven-
tricular geometric factor occurred, but in contrast to norep-
inephrine, left ventricular end-systolic pressure decreased
(6) . Accordingly, unaltered or reduced values for left ventri-
cular end-systolic pressure would be expected and did occur
with low to moderate infusion rates of dopamine (2 and 4 ytg/
kg per min) . The progressive activation of alpha-adrenocep-
tors as the infusion rate of dopamine was increased and the
high degree of variability in the threshold dose for the
activation of these receptors may account for the divergent
responses in left ventricular end-systolic pressure noted at
the 6 pg/kg per min infusion rate.
Role of dopamine receptor activation it improved ventric-
ular performance. Detailed examination of the hemody-
namic responses to dopamine when infused at a rate of 2 µg/
kg per min also supports the notion that activation of
dopamine receptors contributed substantially to the im-
provement in left ventricular systolic performance produced
by the drug
. At this infusion rate, a significant decline in
systemic vascular resistance and left ventricular end-systolic
wall stress was observed, whereas peak positive dP/dt was
not altered appreciably and A Vcf
c increased slightly . The
increase in cardiac output elicited by dopamine al a rate of 2
pg/kg per min would appear to be mediated primarily by a
reduction in left ventricular afterload . Further support for
this interpretation is evident when the hemodynamic re-
sponses to 2 µg/kg per min of dopamine arc compared with
measurements obtained during the infusion ofdobulamine at
a rate of`2 µglkg per min. The magnitude of the changes in A
Vcfr and peak positive dP/dt suggests
,
hat a similar positive
inotropic effect was observed with both drugs . However. left
ventricular end-systolic circumferential wall stress, which
decreased with dopamine, increased with dobutamine . Be-
JACC Vol. 12 . No . 2
August 1988
:498-SM
cause cardiac index was not altered appreciably when dobu-
tamine was infused at a rate of 2 1ag/kg per min, it appears
that afterload reduction was the predominant mechanism
responsible for the increment in cardiac output produced by
2 5ag/kg per min of dopamine . It is reasonable to postulate
that the reduction in left ventricular end-systolic wall stress
observed with dopamine, but not with dobutamine, may
reflect activation of DA I receptors by the former .
Relation between systemic vascular resistance and left
ventricular wall stress . In the current study as well as that of
Lang et al . (10), changes in left ventricular end-systolic wall
stress did not necessarily correspond with those noted for
systemic vascular resistance . Although left ventricular inter-
nal load (that is, wall stress) is related to vascular hydraulic
load, the relation is complicated by the geometry of the
contracting ventricle and the physical properties of the
arterial tree (20) . Moreover, Laskey and colleagues (21,22)
and Yaginuma et al . (23) demonstrated incongruous re-
sponses in systemic vascular resistance and low frequency
moduli of aortic impedance during exercise and with the
administration of nitroglycerin. Alterations in the timing and
magnitude of arterial wave reflections appeared to be the
mechanisms responsible for these observations . i t is con-
ceivable that the lack of total congruence between changes
in left ventricular end-systolic wall stress and systemic
vascular resistance noted in our patients may also be due to
alterations in the reflection properties of the arterial system .
Clinical implications . The results of the present investi-
gation suggest that an oral dopamine analog may be a more
desirable - 'positive inotropic" agent than a pure beta,-
adrenoceptor agonist for the long-term treatment of patients
with heart failure . Because afterload reduction mediated by
way of activation of dopamine vascular
(DA,)
receptors
seems to contribute significantly toward determining the
improvement in left ventricular function produced by dopa-
mine, tolerance to the positive inotropic action of a drug with
betas adrenoceptor activity would tend to have less pro-
found effects on the responses elicited by a dopamine analog
than would those evoked by a selective beta,-adrenoceptor
agonist . Indeed, when levodopa, which is decarboxylated
endogenously to dopamine, was administered on a long-term
basis to patients with heart failure, a sustained improvement
in cardiac function was observed (3) .
Another desirable effect of dopurnine in patients wid,
heart failure is doe brisk natriuresis and dieresis observed
with its administration (15) . Activation of the DA, receptor
in the renal bed appears to be the mechanism predominantly
responsible for the increase in urinary volume and sodium
excretion (17) . A significant natriuresis has also been ob-
served when the angiotensin-converting enzyme inhibitor
captopril is administered in conjunction with furosemide
(24) . However, the reduction in arterial pressure that fre-
quently occurs during the administration of captopril can
abolish the natriuresis and precipitate a deterioration in renal
RAIFER ET AL.
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function (25-27). With dopamine, a reduction in left ventric
ular afterload occurs as with other vasodilating drugs, but
the decrease in systemic arterial pressure, and thus renal
perfusion pressure, that commonly accompanies therapy
with the latter agents is not observed.
Conclusions, The hemodynarhic effects of dopamine in
patients with heart failure appear to he due not only to its
positive inotropic activity but also to afterload reduction .
The decline in left ventricular end-systolic wall stress, an
index of left ventricular afterload, observed with dopamine
but not dobutamine may reflect the contribution of dopamine
vascular
(DA,)
receptor activation toward the improvement
in overall left ventricular performance produced by dopa-
mine
. These observations suggest that an oral dopamine
analog may provide greater clinical benefit than would a
selective beto,-adrenoceptor agonist when administered to
patients with heart failure.
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